FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386802502> ?p ?o ?g. }

• W4386802502 abstract "Military veterans are at increased risk of substance use disorders. Limited research is available about veterans' cannabis use (CU) during the coronavirus disease 2019 (COVID-19) pandemic. This study estimated the prevalence of past 30-day CU, investigated individual-level correlates of past 30-day CU, and evaluated the reasons (medical, recreational, or both) of past 30-day CU among U.S. Veterans during the second wave of the COVID-19 pandemic.We used population-based, cross-sectional data from the 2021 Behavioral Risk Factor Surveillance System Survey Marijuana Use model. The sample included nationally representative military veterans aged 18+ years (n = 11,167). The outcome was past 30-day CU. Individual-level demographic, socioeconomic, behavioral, and clinical correlates were examined. Analyses were weighted to account for the survey's complex design with results generalizable to nearly 2.9 million veterans. We conducted weighted descriptive statistics, prevalence estimates, and multivariable logistic regression analyses.Out of 2.9 million veterans, 11.1% self-reported as non-Hispanic Black, 3.7% Hispanic, and 79.1% non-Hispanic White; 88.5% were men, and 72.8% were aged 50+ years. About 14.6% were current tobacco smokers, 4.7% were current e-cigarette users, 12.5% were binge alcohol drinkers, and 43.4% had three or more comorbid conditions. Overall, 8.5% reported CU in the past 30 days, of which 30.4% used it for medical reasons and 25.8% used it for nonmedical reasons. The prevalence of past 30-day CU decreased with age, education, and income level. Compared to their counterparts, the odds of past 30-day CU were greater among men, those living in urban areas, those with frequent mental distress, infrequent physical distress, and those who had at least one comorbid condition. Non-Hispanic Black veterans had 89% increased odds of past 30-day CU (adjusted odds ratio [AOR] =1.89, 95% confidence interval [CI], 1.19-3.0) compared with non-Hispanic White veterans. Current tobacco smokers had 3.54 (95% CI, 2.40-5.24) and former smokers had 1.78 (95% CI, 1.28-2.47) times higher odds of reporting past 30-day CU than never smokers. Current e-cigarette use (AOR = 3.37, 95% CI, 2.20-5.16) and binge drinking (AOR = 3.18, 95% CI, 2.29-4.41) were also statistically significantly associated with increased odds of past 30-day CU compared to no e-cigarette use and no binge drinking.CU is prevalent among veterans, and certain subgroups are at higher risk of CU. Thus, identifying high-risk subgroups of veterans and adequately educating them about CU's benefits, risks, and safety is crucial." @default.
• W4386802502 created "2023-09-17" @default.
• W4386802502 creator A5004418815 @default.
• W4386802502 creator A5005019211 @default.
• W4386802502 creator A5066817307 @default.
• W4386802502 creator A5069664005 @default.
• W4386802502 creator A5071778397 @default.
• W4386802502 date "2023-09-16" @default.
• W4386802502 modified "2023-09-26" @default.
• W4386802502 title "Prevalence and Correlates of Cannabis Use among U.S. Veterans during the Second Wave of the COVID-19 Pandemic" @default.
• W4386802502 cites W2069459410 @default.
• W4386802502 cites W2746589768 @default.
• W4386802502 cites W2801437766 @default.
• W4386802502 cites W2903026708 @default.
• W4386802502 cites W2947895744 @default.
• W4386802502 cites W2981671343 @default.
• W4386802502 cites W2987298658 @default.
• W4386802502 cites W2989351351 @default.
• W4386802502 cites W2996157445 @default.
• W4386802502 cites W3025984853 @default.
• W4386802502 cites W3082900057 @default.
• W4386802502 cites W3085869051 @default.
• W4386802502 cites W3090018442 @default.
• W4386802502 cites W3120067934 @default.
• W4386802502 cites W3120138201 @default.
• W4386802502 cites W3127968787 @default.
• W4386802502 cites W3132969425 @default.
• W4386802502 cites W3155982608 @default.
• W4386802502 cites W3158206914 @default.
• W4386802502 cites W3173334535 @default.
• W4386802502 cites W3173829831 @default.
• W4386802502 cites W3188016004 @default.
• W4386802502 cites W3190378801 @default.
• W4386802502 cites W3193632411 @default.
• W4386802502 cites W3194006651 @default.
• W4386802502 cites W3196511399 @default.
• W4386802502 cites W3198741798 @default.
• W4386802502 cites W3209798094 @default.
• W4386802502 cites W3217243571 @default.
• W4386802502 cites W4200430769 @default.
• W4386802502 cites W4210922709 @default.
• W4386802502 cites W4229333992 @default.
• W4386802502 cites W4232085753 @default.
• W4386802502 cites W4366496824 @default.
• W4386802502 doi "https://doi.org/10.1093/milmed/usad360" @default.
• W4386802502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37715685" @default.
• W4386802502 hasPublicationYear "2023" @default.
• W4386802502 type Work @default.
• W4386802502 citedByCount "0" @default.
• W4386802502 crossrefType "journal-article" @default.
• W4386802502 hasAuthorship W4386802502A5004418815 @default.
• W4386802502 hasAuthorship W4386802502A5005019211 @default.
• W4386802502 hasAuthorship W4386802502A5066817307 @default.
• W4386802502 hasAuthorship W4386802502A5069664005 @default.
• W4386802502 hasAuthorship W4386802502A5071778397 @default.
• W4386802502 hasBestOaLocation W43868025021 @default.
• W4386802502 hasConcept C118552586 @default.
• W4386802502 hasConcept C126322002 @default.
• W4386802502 hasConcept C142052008 @default.
• W4386802502 hasConcept C142724271 @default.
• W4386802502 hasConcept C144024400 @default.
• W4386802502 hasConcept C147077947 @default.
• W4386802502 hasConcept C149923435 @default.
• W4386802502 hasConcept C151956035 @default.
• W4386802502 hasConcept C190385971 @default.
• W4386802502 hasConcept C2776679223 @default.
• W4386802502 hasConcept C2777056318 @default.
• W4386802502 hasConcept C2777126965 @default.
• W4386802502 hasConcept C2779134260 @default.
• W4386802502 hasConcept C2908647359 @default.
• W4386802502 hasConcept C3008058167 @default.
• W4386802502 hasConcept C3017944768 @default.
• W4386802502 hasConcept C524204448 @default.
• W4386802502 hasConcept C71924100 @default.
• W4386802502 hasConcept C74909509 @default.
• W4386802502 hasConcept C89623803 @default.
• W4386802502 hasConcept C99454951 @default.
• W4386802502 hasConceptScore W4386802502C118552586 @default.
• W4386802502 hasConceptScore W4386802502C126322002 @default.
• W4386802502 hasConceptScore W4386802502C142052008 @default.
• W4386802502 hasConceptScore W4386802502C142724271 @default.
• W4386802502 hasConceptScore W4386802502C144024400 @default.
• W4386802502 hasConceptScore W4386802502C147077947 @default.
• W4386802502 hasConceptScore W4386802502C149923435 @default.
• W4386802502 hasConceptScore W4386802502C151956035 @default.
• W4386802502 hasConceptScore W4386802502C190385971 @default.
• W4386802502 hasConceptScore W4386802502C2776679223 @default.
• W4386802502 hasConceptScore W4386802502C2777056318 @default.
• W4386802502 hasConceptScore W4386802502C2777126965 @default.
• W4386802502 hasConceptScore W4386802502C2779134260 @default.
• W4386802502 hasConceptScore W4386802502C2908647359 @default.
• W4386802502 hasConceptScore W4386802502C3008058167 @default.
• W4386802502 hasConceptScore W4386802502C3017944768 @default.
• W4386802502 hasConceptScore W4386802502C524204448 @default.
• W4386802502 hasConceptScore W4386802502C71924100 @default.
• W4386802502 hasConceptScore W4386802502C74909509 @default.
• W4386802502 hasConceptScore W4386802502C89623803 @default.
• W4386802502 hasConceptScore W4386802502C99454951 @default.
• W4386802502 hasLocation W43868025021 @default.
• W4386802502 hasLocation W43868025022 @default.

• next